Biblio Discovery — Demo Discovery Service

808 results

Showing 1–20 · 0.32 seconds · RSS

Journal

Experimental Hematology & Oncology

Scopus

ISSN 2162-3619 · BMC · 808 articles in the index

  1. Journal Article

    Resilience of human tolerogenic dendritic cells to physiological oxygen supports clinical application: functional stability amidst glycolytic and differentiation shifts

    Antonia Peter; Tamara Traitteur; Sara Calitz et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Tolerogenic dendritic cells (tolDCs) hold promise for treating autoimmune diseases, potentially restoring antigen-specific immune tolerance without systemic immunosuppression. However, their behavior in vivo remains incompletely understood, particularly in response to microenvironmental…

  2. Journal Article

    Organoids for disease modeling and treatment: state-of-the-art

    Mingyi Xu; Dexiao Kong; Shan Sun et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The emergence of organoids has received widespread attention for faithful recapitulation of physiological and pathological conditions, together with overcoming the major bottleneck of extrapolating laboratory findings from model systems to human organs. Organoid technologies are one of the…

  3. Journal Article

    ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils

    Yuhan He; Ya Zhou; Dexin Wen et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The genes controlling lineage determination and differentiation tend to be essential for the development of acute myeloid leukemia (AML). Identifying novel target genes capable of promoting the differentiation and maturation of undifferentiated leukemia cells offers a promising…

  4. Journal Article

    Synthetic essentiality of isoprenylcysteine carboxylmethyltransferase in PTEN deficient triple negative breast cancer

    Byung-Sun Park; Jaeyeol Kim; Dong-Chan Seo et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract PTEN deficiency is frequently observed in various cancers, including triple-negative breast cancer. However, PTEN loss-of-function mutations are not directly druggable, necessitating a synthetic lethality approach for treating PTEN-deficient tumors. Utilizing combinatorial CRISPR…

  5. Journal Article

    Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma

    Chenggong Tu; Arne Van der Vreken; Fien Meeus et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Introduction Multiple myeloma (MM) develops in the hypoxic bone marrow (BM) microenvironment, which alters tumor behavior and immune responses. While hypoxia is known to directly suppress immune function, its effect on immunotherapy-relevant antigen expression and the MM secretome remains…

  6. Journal Article

    Tertiary lymphoid structures correlate with reduced recurrence risk and enhanced antitumor immunity in esophageal squamous cell carcinoma with pathologic non-complete response to neoadjuvant chemoimmunotherapy

    Yang Wo; Tong Lu; Zijiang Yang et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The majority of patients with locally advanced esophageal squamous cell carcinoma (ESCC) undergoing neoadjuvant chemoimmunotherapy (nCIT) failed to achieve pathologic complete response (pCR), had high risk of postoperative recurrence and lacked prognostic biomarkers. Tertiary…

  7. Journal Article

    In vivo CAR-T engineering: insights from the 2025 ASH annual meeting

    Gelayol Asadi; Misagh Rajabinejad

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract In vivo chimeric antigen receptor (CAR)-T engineering is a prominent field of research in cancer immunology, in which vectors are used to reprogram endogenous T-cells into CAR-T cells. Viral and nonviral platforms presented at the 67th Annual Meeting of the American Society of Hematology…

  8. Journal Article

    The influence of neuro-tumor interactions on tumorigenesis and therapeutic response

    Xiaokang Wang; Yuanliang Yan; Liugen Li et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The intricate crosstalk between the nervous system and tumors has emerged as a pivotal determinant of tumorigenesis, progression, and therapeutic response. This review synthesizes current insights into neuro-tumor interactions, highlighting how neuronal networks within the tumor…

  9. Journal Article

    Mutation rates in main tumour driver genes predict prognosis in patients with superficial spreading or nodular primary melanoma: results from the CARAMEL study by the Italian Melanoma Intergroup (IMI)

    Maria Cristina Sini; Jerry Polesel; Sara Simi et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Superficial spreading melanoma (SSM) and nodular melanoma (NM) are the two histotypes that account for most cutaneous primary melanomas. We evaluated the mutational status for the genes underlying melanomagenesis among a series of SSMs and NMs from different Italian geographical areas. An…

  10. Journal Article

    Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML

    Guo Qiu; Zhao Yin; Xiaoyue Lu et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background TP53-mutated acute myeloid leukemia (AML) represents one of the most adverse-risk subtypes of AML, yet the mechanisms underlying its resistance and relapse remain poorly defined. Methods We performed single-cell RNA sequencing on bone marrow samples from 30 de novo AML patients…

  11. Journal Article

    Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition

    Andreas Ritter; Samira Catharina Hoock; Nina-Naomi Kreis et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The tumor microenvironment (TME) in breast cancer is shaped by reciprocal interactions between cancer cells and their surrounding stromal populations. Here, we show that breast adipose tissue-derived stromal/stem cells (bASCs) undergo distinct state transitions in response to tumor cues…

  12. Journal Article

    From Amphiphiles to mRNA platforms: emerging vaccination strategies for pancreatic cancer

    Dong Gun Lee; Kyunghee Noh

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Pancreatic ductal adenocarcinoma (PDAC) remains among the deadliest cancers, with limited surgical eligibility, modest chemotherapy benefit, and resistance to immune checkpoint blockade. Two recent vaccine platforms have shown encouraging results. Wainberg et al. demonstrated that the…

  13. Journal Article

    Tumor-intrinsic PD-L1 drives lung cancer progression in response to TLR stimulation by promoting autophagy through the TRAF6–BECN1 signaling axis

    Yoolim Sung; Ha-Jeong Lee; Mi-Jeong Kim et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Programmed death-ligand 1 (PD-L1, CD274) is well known for its immunosuppressive function within the tumor microenvironment; however, its tumor cell–intrinsic roles remain incompletely characterized. Emerging evidence suggests that PD-L1 may regulate oncogenic processes beyond…

  14. Journal Article

    Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance

    Haoxiang Zhang; Chuanbing Zhao; Jiaoshun Chen et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Alterations in extracellular matrix (ECM) architecture and stiffness are hallmarks of aggressive pancreatic cancer progression. However, the mechanisms by which ECM biomechanical properties regulate malignant biological behavior remain unknown. Here, we reveal that calmodulin-dependent…

  15. Journal Article

    Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response

    Kailin Qiao; Leilei Wu; Letong Yang et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Remarkable progress has been made in cancer immunotherapy in recent years; however, it still faces challenges such as limited response rates, resistance, and immune-related adverse events. Ubiquitination, a key post-translational modification (PTM) of proteins, is indispensable for…

  16. Journal Article

    Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer

    Youwen Zhu; Kun Liu; Hong Zhu

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Epigenetics shapes all aspects of cancer occurrence and progression. Among them, chromatin methylation is a particularly important regulator of oncogenic processes. The dynamic shifts in methylation can influence the development or death of tumor cells. In the therapeutic context…

  17. Journal Article

    Single-cell profiling reveals FAM117A as a key regulator linking macrophage–epithelial crosstalk with the progression of lung adenocarcinoma

    Chao Wu; Zhipeng Ren; Gang Che et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The tumor microenvironment (TME) has a profound influence on the progression of lung adenocarcinoma (LUAD) and its response to therapy. We identified a tumor-promoting communication network based on single-cell RNA sequencing. This shows an SPP1 + macrophage and basal epithelial cell…

  18. Journal Article

    Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types

    Yaya Yu; Yanan Li; Jiao Wang et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Lack of pre-clinical models that simulate the complex TME and translate to human immunity is list as the top one challenge in the area of cancer immunotherapy development. While newly emerging organoid models play a crucial role in promoting the development of precision medicine in cancer…

  19. Journal Article

    Molecular background of Philadelphia chromosome dependent enhancement of cellular growth and tyrosine kinase inhibitor sensitivity

    Md Faruq Hossain; Lisa Hagenau; Lars R. Jensen et al.

    Experimental Hematology & Oncology, Vol. 15 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The Philadelphia chromosome is the result of a balanced reciprocal translocation between the long arms of chromosomes 9 and 22, resulting in the fusion gene BCR-ABL1. Despite it being a hallmark of acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML) and mixed-phenotype acute…